This policy differentiates case reports from human subjects research.

Clinical investigations involving human subjects and drugs, biologics, devices or test articles are subject to review. In order to comply with federal regulations, the IRB will determine what types of applications and exemptions (when applicable) are required for the study. This document describes various types of studies and instructions for submission and compliance.

This policy describes the process by which the IRB determines if risks are minimized for participants in a proposed project. Review process and relevant definitions are included in the document.

This policy requires the implenmentation of a quality assurance and quality improvement program to monitor compliance with federal regulations and improve the Human Research Protection Program processes

This policy outlines the requirements for formulating contracts with sponsors of proposed research.

These guidelines implement portions of the Board policy on non-resident tuition, certification of residency status, and appeals.

This policy describes The Office of Student's Life's requirement for full-time employees and certain others to wear a staff uniform shirt.

This policy describes the IRB's obligation to report certain determinations to UAB officials, regulatory and other federal regulatory agencies, and sponsors.

This policy outlines UAB's approach to determining whether use of commercially available cell lines is defined as human subjects research.

This policy details the process for reviewing and handling financial (or other) conflicts of interest surrounding the investigator of a proposed project.